Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
The primary objective was to assess the effect of Xepol compared to placebo on physical
health and on muscle strength in subjects with post-polio syndrome.The secondary objective
was to assess the effect of Xepol compared to placebo on functional balance, activity
patterns, pain, fatigue, sleep, vitality, muscular strength, pulmonary capacity, walking
ability, balance and safety.